CGTX
Cognition Therapeutics, Inc.$1.26-0.01 (-1.17%)Prev Close$1.28·MCap$94.2M·P/E—·Vol283.8K·Yield—
▲
Buys (12M)
3
$32.5K
▼
Sells (12M)
13
$283.7K
◆
Net Activity
Net Seller
$251.2K
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Cognition Therapeutics, Inc. (CGTX) has been dominated by selling, with 3 insider purchases totaling $32.5K and 13 insider sales totaling $283.7K. The most recent insider transaction was by Caggiano Anthony (officer: Chief Medical Officer), who purchased $11.1K worth of shares on Apr 20, 2026. Cognition Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $94.2M.
CGTX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Caggiano Anthony | officer: Chief Medical Officer | Buy | 10,000 | $1.11 | $11.1K | 874,906 |
| Apr 20, 2026 | Doyle John Brendan | officer: Chief Financial Officer | Buy | 10,000 | $1.13 | $11.3K | 627,509 |
| Apr 20, 2026 | Ricciardi Lisa | director, officer: CEO & President | Buy | 9,175 | $1.10 | $10.1K | 1,715,851 |
| Feb 15, 2026 | Caggiano Anthony | Chief Medical Officer | Sell | 4,680 | $1.12 | $5.2K | 0 |
| Feb 15, 2026 | Doyle John Brendan | Chief Financial Officer | Sell | 1,560 | $1.12 | $1.7K | 0 |
| Feb 15, 2026 | Ricciardi Lisa | CEO & President | Sell | 5,850 | $1.12 | $6.6K | 0 |
| Feb 3, 2026 | Caggiano Anthony | Chief Medical Officer | Sell | 38,407 | $1.06 | $40.6K | 0 |
| Feb 3, 2026 | Doyle John Brendan | Chief Financial Officer | Sell | 26,921 | $1.03 | $27.7K | 0 |
| Feb 3, 2026 | Ricciardi Lisa | CEO & President | Sell | 77,740 | $1.06 | $82.4K | 0 |
| Dec 18, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 20,280 | $1.50 | $30.4K | 0 |
| Dec 18, 2025 | Doyle John Brendan | Chief Financial Officer | Sell | 9,360 | $1.50 | $14.0K | 0 |
| Dec 18, 2025 | Ricciardi Lisa | CEO & President | Sell | 23,400 | $1.50 | $35.1K | 0 |
| Jul 29, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 20,281 | $0.67 | $13.6K | 0 |
| Jul 29, 2025 | Doyle John Brendan | Chief Financial Officer | Sell | 9,360 | $0.67 | $6.3K | 0 |
| Jul 29, 2025 | Ricciardi Lisa | CEO & President | Sell | 23,400 | $0.67 | $15.7K | 0 |
| May 1, 2025 | Doyle John Brendan | Chief Financial Officer | Sell | 9,692 | $0.45 | $4.3K | 0 |
| Feb 15, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 5,296 | $0.59 | $3.1K | 0 |
| Feb 15, 2025 | Doyle John Brendan | Chief Financial Officer | Sell | 1,723 | $0.59 | $1.0K | 0 |
| Feb 15, 2025 | Ricciardi Lisa | CEO & President | Sell | 6,619 | $0.59 | $3.9K | 0 |
| Feb 3, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 12,779 | $0.67 | $8.5K | 0 |
| Jan 31, 2025 | Ricciardi Lisa | CEO & President | Buy | 38,851 | $0.77 | $30.0K | 0 |
| Jan 31, 2025 | Ricciardi Lisa | CEO & President | Sell | 28,960 | $0.67 | $19.3K | 0 |
| May 1, 2024 | Doyle John Brendan | Chief Financial Officer | Sell | 8,699 | $1.95 | $17.0K | 0 |
| Mar 14, 2024 | Ricciardi Lisa | CEO & President | Buy | 5,700 | $1.75 | $10.0K | 0 |
| Feb 3, 2024 | Caggiano Anthony | Chief Medical Officer | Sell | 12,777 | $2.29 | $29.3K | 0 |
| Feb 3, 2024 | Ricciardi Lisa | CEO & President | Sell | 27,828 | $2.29 | $63.7K | 0 |
| Nov 29, 2022 | RICHSTONE ELLEN B | Director | Buy | 10,000 | $2.66 | $26.6K | 0 |
| Nov 28, 2022 | Fletcher Aaron G.L. | Director | Buy | 16,064 | $2.65 | $42.6K | 0 |
| Nov 16, 2022 | Fletcher Aaron G.L. | Director | Buy | 71,000 | $1.40 | $99.4K | 0 |
| Nov 15, 2022 | Fletcher Aaron G.L. | Director | Buy | 1,500,000 | $1.20 | $1.80M2.0% OS | 0 |
| Nov 15, 2022 | Ricciardi Lisa | CEO & President | Buy | 12,000 | $1.30 | $15.6K | 0 |
| Nov 15, 2022 | Wallace Peggy | Director | Buy | 12,500 | $1.20 | $15.0K | 0 |
| Oct 13, 2021 | Breedlove Mark H. | Director | Sell | 12 | $11.74 | $140.88 | 0 |
| Oct 13, 2021 | Fletcher Aaron G.L. | Director | Buy | 190,000 | $12.00 | $2.28M | 0 |
| Oct 13, 2021 | Fletcher Aaron G.L. | Director | Sell | 33,585 | $0.06 | $2.2K | 0 |
| Oct 13, 2021 | O'Brien James Michael | Chief Financial Officer | Buy | 5,000 | $12.00 | $60.0K | 0 |
| Oct 13, 2021 | Ricciardi Lisa | CEO & President | Buy | 12,500 | $12.00 | $150.0K | 0 |
| Oct 13, 2021 | Wallace Peggy | Director | Buy | 3,000 | $12.00 | $36.0K | 0 |
CGTX Insider Buying Activity
The following table shows recent insider purchases of Cognition Therapeutics, Inc. (CGTX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Caggiano Anthony | officer: Chief Medical Officer | Buy | 10,000 | $1.11 | $11.1K | 874,906 |
| Apr 20, 2026 | Doyle John Brendan | officer: Chief Financial Officer | Buy | 10,000 | $1.13 | $11.3K | 627,509 |
| Apr 20, 2026 | Ricciardi Lisa | director, officer: CEO & President | Buy | 9,175 | $1.10 | $10.1K | 1,715,851 |
| Jan 31, 2025 | Ricciardi Lisa | CEO & President | Buy | 38,851 | $0.77 | $30.0K | 0 |
| Mar 14, 2024 | Ricciardi Lisa | CEO & President | Buy | 5,700 | $1.75 | $10.0K | 0 |
| Nov 29, 2022 | RICHSTONE ELLEN B | Director | Buy | 10,000 | $2.66 | $26.6K | 0 |
| Nov 28, 2022 | Fletcher Aaron G.L. | Director | Buy | 16,064 | $2.65 | $42.6K | 0 |
| Nov 16, 2022 | Fletcher Aaron G.L. | Director | Buy | 71,000 | $1.40 | $99.4K | 0 |
| Nov 15, 2022 | Fletcher Aaron G.L. | Director | Buy | 1,500,000 | $1.20 | $1.80M2.0% OS | 0 |
| Nov 15, 2022 | Ricciardi Lisa | CEO & President | Buy | 12,000 | $1.30 | $15.6K | 0 |
| Nov 15, 2022 | Wallace Peggy | Director | Buy | 12,500 | $1.20 | $15.0K | 0 |
| Oct 13, 2021 | Fletcher Aaron G.L. | Director | Buy | 190,000 | $12.00 | $2.28M | 0 |
| Oct 13, 2021 | O'Brien James Michael | Chief Financial Officer | Buy | 5,000 | $12.00 | $60.0K | 0 |
| Oct 13, 2021 | Ricciardi Lisa | CEO & President | Buy | 12,500 | $12.00 | $150.0K | 0 |
| Oct 13, 2021 | Wallace Peggy | Director | Buy | 3,000 | $12.00 | $36.0K | 0 |
CGTX Insider Selling Activity
The following table shows recent insider sales of Cognition Therapeutics, Inc. (CGTX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 15, 2026 | Caggiano Anthony | Chief Medical Officer | Sell | 4,680 | $1.12 | $5.2K | 0 |
| Feb 15, 2026 | Doyle John Brendan | Chief Financial Officer | Sell | 1,560 | $1.12 | $1.7K | 0 |
| Feb 15, 2026 | Ricciardi Lisa | CEO & President | Sell | 5,850 | $1.12 | $6.6K | 0 |
| Feb 3, 2026 | Caggiano Anthony | Chief Medical Officer | Sell | 38,407 | $1.06 | $40.6K | 0 |
| Feb 3, 2026 | Doyle John Brendan | Chief Financial Officer | Sell | 26,921 | $1.03 | $27.7K | 0 |
| Feb 3, 2026 | Ricciardi Lisa | CEO & President | Sell | 77,740 | $1.06 | $82.4K | 0 |
| Dec 18, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 20,280 | $1.50 | $30.4K | 0 |
| Dec 18, 2025 | Doyle John Brendan | Chief Financial Officer | Sell | 9,360 | $1.50 | $14.0K | 0 |
| Dec 18, 2025 | Ricciardi Lisa | CEO & President | Sell | 23,400 | $1.50 | $35.1K | 0 |
| Jul 29, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 20,281 | $0.67 | $13.6K | 0 |
| Jul 29, 2025 | Doyle John Brendan | Chief Financial Officer | Sell | 9,360 | $0.67 | $6.3K | 0 |
| Jul 29, 2025 | Ricciardi Lisa | CEO & President | Sell | 23,400 | $0.67 | $15.7K | 0 |
| May 1, 2025 | Doyle John Brendan | Chief Financial Officer | Sell | 9,692 | $0.45 | $4.3K | 0 |
| Feb 15, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 5,296 | $0.59 | $3.1K | 0 |
| Feb 15, 2025 | Doyle John Brendan | Chief Financial Officer | Sell | 1,723 | $0.59 | $1.0K | 0 |
| Feb 15, 2025 | Ricciardi Lisa | CEO & President | Sell | 6,619 | $0.59 | $3.9K | 0 |
| Feb 3, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 12,779 | $0.67 | $8.5K | 0 |
| Jan 31, 2025 | Ricciardi Lisa | CEO & President | Sell | 28,960 | $0.67 | $19.3K | 0 |
| May 1, 2024 | Doyle John Brendan | Chief Financial Officer | Sell | 8,699 | $1.95 | $17.0K | 0 |
| Feb 3, 2024 | Caggiano Anthony | Chief Medical Officer | Sell | 12,777 | $2.29 | $29.3K | 0 |
| Feb 3, 2024 | Ricciardi Lisa | CEO & President | Sell | 27,828 | $2.29 | $63.7K | 0 |
| Oct 13, 2021 | Breedlove Mark H. | Director | Sell | 12 | $11.74 | $140.88 | 0 |
| Oct 13, 2021 | Fletcher Aaron G.L. | Director | Sell | 33,585 | $0.06 | $2.2K | 0 |
CGTX Insiders
Ricciardi Lisa
director, officer: CEO & President
Bought $215.7KSold $226.7K
12 tradesLast: Apr 20, 2026
Doyle John Brendan
officer: Chief Financial Officer
Bought $11.3KSold $72.1K
8 tradesLast: Apr 20, 2026
Similar Stocks to CGTX
VRTX
Vertex Pharmaceuticals Incorporated
$429.19+0.77%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$740.38-0.55%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$305.79-0.88%
$41.24B
INSM
Insmed Incorporated
$133.47-1.85%
$30.79B
RVMD
Revolution Medicines, Inc.
$146.58+11.18%
$29.51B
UTHR
United Therapeutics Corporation
$566.52-0.06%
$25.13B
MRNA
Moderna, Inc.
$46.88-3.78%
$21.42B
RPRX
Royalty Pharma plc
$49.86+0.42%
$21.20B